Cynata Therapeutics (CYYNF)
(Delayed Data from OTC)
$0.19 USD
0.00 (0.00%)
Updated Jun 13, 2024 02:41 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Cynata Therapeutics Ltd. [CYYNF]
Reports for Purchase
Showing records 1 - 20 ( 35 total )
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
High-Profile Licensing Deal Underscores Cell Therapy Value; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
CYP-004 Phase 3 SCUlpTOR Trial Commences; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Positive CYP-001 Two-Year Long-Term Follow-Up Clinical Data; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Clinical Progress on Multiple Fronts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Preclinical Sepsis Data Hint at Therapeutic Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Dainippon Sumitomo Takeover Bid Withdrawn; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
FUJIFILM Exercises Option; Dainippon Sumitomo Acquisition Offer Remains Pending; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
FUJIFILM Delay Merely a Bump in the Road, We Believe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Research Funding Awarded; Tax Credits Received; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Recent Developments Underscore Clinical Progress; FUJIFILM May Exercise Option Soon; Raising Target to A$2
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
CYP-001 Meets Safety and Efficacy Endpoints in Phase 1 Graft-vs.-Host Disease Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
CYP-001 Phase 1 Trial Enrollment Completed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
FDA Grants CYP-001 Orphan Drug Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Cohort A Primary Evaluation Period Data Comes up Trumps; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Data Safety Monitoring Board Clears Trial to Enter Cohort B; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
First Cohort Enrollment Completed in CYP-001 Clinical Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Upcoming Milestones Could Prove Transformative; Reiterate Buy and Raising Target to A$1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Advances in Asthma; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Cynata Therapeutics Ltd.
Industry: Medical - Biomedical and Genetics
Advances in Asthma; Reiterate Buy
Provider: Rodman & Renshaw, Co.